PPAR-alpha agonist treatment increases trefoil factor family-3 expression and attenuates apoptosis in the liver tissue of bile duct-ligated rats

Turkish Journal of Gastroenterology

Volumn 24, Issue 2, 2013, Pages 134-140

  Karakan, Tarkan ^a   Kerem, Mustafa ^a   Cindoruk, Mehmet ^a   Engin, Doruk ^a   Alper, Murat ^b   Akin, Okan ^b  

^a GAZI UNIVERSITY   (Turkey)

^b Dşflkapi Training and Research Hospital ^*  (Turkey)

Author keywords

Bile duct ligated rats; Cholestasis; PPAR alpha; Trefoil factor family

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYTOKINE; FENOFIBRATE; FREE RADICAL; GAMMA GLUTAMYLTRANSFERASE; INTERLEUKIN 1BETA; INTESTINAL TREFOIL FACTOR; MALONALDEHYDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BILE DUCT LIGATION; BLOOD SAMPLING; CONTROLLED STUDY; INTRAHEPATIC CHOLESTASIS; LIPID PEROXIDATION; LIVER DISEASE; LIVER FUNCTION TEST; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; WISTAR RAT;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; BILE DUCTS; BILIRUBIN; FENOFIBRATE; GAMMA-GLUTAMYLTRANSFERASE; HYPOLIPIDEMIC AGENTS; INTERLEUKIN-1BETA; LIGATION; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; NEUROPEPTIDES; PPAR ALPHA; RATS; RATS, WISTAR; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84880882540     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2013.0605     Document Type: Article

References (31)

1. Wong WM, Poulsom R, Wright NA. Trefoil peptides. Gut 1999; 44: 890-4.
2. Wright NA, Poulsom R, Stamp G, et al. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993; 104: 12-7.
3. May FE, Westley BR. Trefoil proteins: their roles in normal and malignant cells. J Pathol 1997; 183: 4-7.
4. Perry JK, Kannan N, Grandison PM, et al. Are trefoil factors oncogenic? Trends Endocrinol Metab 2008; 19: 74-81.
5. Dhar DK, Wang TC, Tabara H, et al. Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis. Clin Cancer Res 2005; 11: 6472-8.
6. Srivatsa G, Giraud AS, Ulaganathan M, et al. Biliary epithelial trefoil peptide expression is increased in biliary diseases. Histopathology 2002; 40: 261-8.
7. Seitz G, Theisinger B, Tomasetto G, et al. Breast cancer-associated protein pS2 expression in tumors of the biliary tract. Am J Gastroenterol 1991; 86: 1491-4.
8. Idilman R, Erden E, Arat M, et al. Trefoil factor expression in biliary epithelium of graft-versus-host disease of the liver after allogeneic hematopoietic cell transplantation. Transplantation 2005; 80: 1099-104.
9. Bensinger SJ, Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 2008; 454: 470-7.
10. Wang YD, Chen WD, Wang M, et al. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response. Hepatology 2008; 48: 1632-43.
11. De Bosscher K, Haegeman G. Minireview: latest perspectives on anti-inflammatory actions of glucocorticoids. Mol Endocrinol 2009; 23: 281-91.
12. Lee J, Hong EM, Byun HW, et al. The effect of PPARalpha and PPARgamma ligands on inflammation and ABCA1 expression in cultured gallbladder epithelial cells. Dig Dis Sci 2008; 53: 1707-15.
13. Pemsingh RS, Macpherson BR, Scott GW. Characterization of lipid accumulation in the gallbladder mucosa of the ground squirrel fed a lithogenic diet. J Pathol 1988; 154: 173-80.
14. Montanaro MA, Bernasconi AM, Gonzalez MS, et al. Effects of fenofibrate and insulin on the biosynthesis of unsaturated fatty acids in streptozotocin diabetic rats. Prostaglandins Leukot Essent Fatty Acids 2005; 73: 369-78.
15. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8.
16. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
17. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
18. Kimura Y, Leung PSC, Kenny TP, et al. Differential expression of intestinal trefoil factor in biliary epithelial cells of primary biliary cirrhosis. Hepatology 2002; 36: 1227.
19. Trauner M, Meierer PJ, Boyer JL. Molecular pathogenesis of cholestasis. New Engl J Med 1998; 39: 1217-27.
20. Weis HJ, Dietschy JM. Presence of an intact cholesterol feedback mechanism in the liver in biliary stasis. Gastroenterology 1971; 61: 77-84.
21. Jacinto A, Martinez-Arias A, Martin P. Mechanisms of epithelial fusion and repair. Nat Cell Biol 2001; 3: E117-23.
22. Demetris AJ, Sakamoto T, Liu Z, et al. The ductular reaction in liver disease emphasis on a type I response. In: Fleig WE, ed. Normal and malignant liver cell growth. Dordecht: Kluwer Academic Publishers, 1999; 141-55.
23. Mashimo H, Wu DC, Podolsky DK, Fishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996; 274: 262-5.
24. Kindon H, Pothoulakis C, Thim L, et al. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 1995; 109: 516-23.
25. Tomasetto C, Masson R, Linares JL, et al. pS2/TFF1 interacts directly with the VWFC cysteine rich domains of mucins. Gastroenterology 2000; 118: 70-80.
26. Gum JR Jr, Hicks JW, Gillespie AM, et al. Goblet cell-specific expression mediated by the MUC2 mucin gene promoter in the intestine of transgenic mice. Am J Physiol 1999; 276: G666-G676.
27. Kanai M, Mullen C, Podolsky DK. Intestinal trefoil factor induces inactivation of extracellular signal-regulated protein kinase in intestinal epithelial cells. Proc Natl Acad Sci USA 1998; 95: 178-82.
28. Ernst M, Inglese M, Waring P, et al. Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med 2001; 194: 189-203.
29. Nozaki I, Lunz JG 3rd, Specht S, et al. Regulation and function of trefoil factor family 3 expression in the biliary tree. Am J Pathol 2004; 165: 1907-20.
30. Firrincieli D, Zuniga S, Poupon R, et al. Role of nuclear receptors in the biliary epithelium. Dig Dis 2011; 29: 52-7.
31. Chakravarthy MV, Lodhi IJ, Yin L, et al. Identification of a physiologically relevant endogenous ligand for PPARalpha in liver. Cell 2009; 138: 476-88.